OpenAI and Anthropic are preparing to go public within the next year or two, with Anthropic's IPO potentially raising as much as $2 trillion and OpenAI targeting $1.4 trillion, though OpenAI has pushed its listing to 2027 over AI safety concerns. Researchers note that such windfalls could add to an already growing trend of tech entrepreneurs funneling personal fortunes into biomedical science, citing examples like Altos Labs, which launched in 2022 with $3 billion from investors including Yuri Milner and Jeff Bezos, and the Chan Zuckerberg Initiative.
nature.com
· 2026-10-21
A study published in JAMA found that mandatory testosterone screening ordered by Defense Secretary Pete Hegseth could flag up to a quarter of active-duty Army members as having low testosterone, even though the true prevalence of the condition is likely far lower. Researchers from Pennington Biomedical Research Center and the US Army Research Institute of Environmental Medicine analyzed blood samples from 479 male soldiers across five Army installations, collected between August 2024 and January 2026.
arstechnica.com
· 2026-10-15
According to reports from The Washington Post, New York Times and Politico, the White House is drafting an executive order that would let OMB Director Russell Vought approve or reject every grant awarded by the NIH. The move follows a meeting in which NIH Director Jay Bhattacharya reportedly failed to stop the effort, marking the latest attempt by Vought to steer the agency's funding decisions after earlier attempts to cut its budget and impose political criteria on grants were blocked by Congress and the courts.
arstechnica.com
· 2026-09-21
GoKawiil